These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3440840)

  • 1. [Cancer of the prostate with predominant lymphatic manifestation. Apropos of 2 cases].
    Herer B; Waligora J; Delfraissy JF; Dormont J
    J Urol (Paris); 1987; 93(8):475-7. PubMed ID: 3440840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
    Gaur S; Aish LS; Oo TH
    J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymphatic metastasis in prostatic carcinoma. Diagnostic value of staging and transcutaneous needle biopsy].
    Rothenberger K; Hofstetter A; Pfeifer KJ; Voeth C; Pensel J
    Fortschr Med; 1980 Sep; 98(34):1279-82. PubMed ID: 7461533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the prostate.
    Swanson JO
    J Insur Med; 1997; 29(3):195-203. PubMed ID: 10176369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic cancer presenting as palpable lymph node metastasis--report of three cases].
    Masuda H; Yamada T; Nagahama K; Nagamatsu H; Negishi T
    Hinyokika Kiyo; 1992 Nov; 38(11):1269-72. PubMed ID: 1485580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncologic after-care of patients with prostate cancer].
    Friedrich A; Glass W
    Z Urol Nephrol; 1986 Apr; 79(5):269-75. PubMed ID: 2426869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are monotherapy options reasonable for T3 prostate cancer?
    Schellhammer PF; Lynch DF
    Semin Urol Oncol; 1997 Nov; 15(4):207-14. PubMed ID: 9421447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostatic cancer: pathological analysis of autopsied cases].
    Takahashi Y; Mayuzumi T; Satoh J
    Hinyokika Kiyo; 1986 Jun; 32(6):835-9. PubMed ID: 3766343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the prostate.
    Von Eschenbach AC; Johnson DE
    Compr Ther; 1978 Aug; 4(8):18-26. PubMed ID: 688739
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis].
    Tsuzuki M; Kawakami S; Yonese J; Ueda T; Kageyama S; Yamauchi T; Kawai T
    Hinyokika Kiyo; 1994 Sep; 40(9):837-40. PubMed ID: 7801848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on adenocarcinoma of the prostate].
    Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
    Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orbital metastasis of prostatic cancer. Clinical and therapeutic aspects. Apropos of a case (clinical case)].
    Aubert J; Irani J; Saint-Blancat P
    Chirurgie; 1997 Jan; 121(9-10):672-5. PubMed ID: 9138330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].
    Saint-André JP; Rousselet MC; Six P; Bertrand G; Soret JY
    Bull Cancer; 1985; 72(5):414-22. PubMed ID: 4074910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of stage T1b (A2) and stage T1c adenocarcinoma of the prostate.
    Konety BR; Bahnson RR
    Semin Urol Oncol; 1996 Aug; 14(3):183-94. PubMed ID: 8865482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostatic cancer in a young adult: a report of 2 cases].
    Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
    Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and evaluation of the extent of cancer of the prostate].
    Heintz J; Le Fur R; Graïc Y; Hernandez J; Hun Seng S; Bézier J
    Sem Hop; 1983 Oct; 59(36):2557-60. PubMed ID: 6316515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.